iShares Biotechnology ETF $IBB Shares Sold by FRG Family Wealth Advisors LLC

FRG Family Wealth Advisors LLC decreased its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 13.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 21,459 shares of the financial services provider’s stock after selling 3,338 shares during the quarter. FRG Family Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $3,622,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC grew its position in iShares Biotechnology ETF by 46,806.0% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 46,906 shares of the financial services provider’s stock worth $7,927,000 after buying an additional 46,806 shares during the last quarter. Aster Capital Management DIFC Ltd acquired a new position in iShares Biotechnology ETF in the third quarter worth approximately $1,907,000. Central Pacific Bank Trust Division grew its position in iShares Biotechnology ETF by 296,500.0% in the fourth quarter. Central Pacific Bank Trust Division now owns 14,830 shares of the financial services provider’s stock worth $2,503,000 after buying an additional 14,825 shares during the last quarter. SG Americas Securities LLC grew its position in iShares Biotechnology ETF by 96.3% in the third quarter. SG Americas Securities LLC now owns 28,569 shares of the financial services provider’s stock worth $4,125,000 after buying an additional 14,016 shares during the last quarter. Finally, Florin Court Capital LLP acquired a new position in shares of iShares Biotechnology ETF in the third quarter worth about $11,116,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.2%

Shares of IBB opened at $168.50 on Wednesday. iShares Biotechnology ETF has a one year low of $107.43 and a one year high of $179.64. The company has a 50-day moving average of $170.28 and a two-hundred day moving average of $165.67.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Tuesday, March 17th were issued a $0.1218 dividend. This represents a $0.49 annualized dividend and a dividend yield of 0.3%. The ex-dividend date was Tuesday, March 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.